Using Dilute Vinegar to Find Changes in Cells During Endoscopy for Patients With Barrett's Oesophagus (The ABBA Study) (ABBA)
Acetic Acid Guided Biopsies in Barrett's Surveillance for Neoplasia Detection Versus Non-targeted Biopsies (Seattle Protocol): A Feasibility Study for a Randomised Tandem Endoscopy Trial. The ABBA Study.
Sponsor: Brighton and Sussex University Hospitals NHS Trust
This NA trial investigates Barrett Esophagus and is currently completed. Brighton and Sussex University Hospitals NHS Trust leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Study Description(click to expand)This is a feasibility study to enable powering of a larger study. The investigators would assume a disease detection of 4.5% with acetic acid chromoendoscopy and 1.5% with protocol driven mapping biopsies. However, these assumptions are largely driven from a single centre cohort study and as such need clarification before they could be used for the purposes of powering a study. Based on the historical cohort studies and wide consultation within the British Society of Gastroenterology research committee and consultation with experts in the field, it is estimated that 200 patients would be reasonable for recruitment to enable the reproducibility and generalisability of this data to be established. The purpose of this study is not to produce statistically significant data in itself but to establish likely event rates and effect size to inform the power calculation for the definitive study.
This is a feasibility study to enable powering of a larger study. The investigators would assume a disease detection of 4.5% with acetic acid chromoendoscopy and 1.5% with protocol driven mapping biopsies. However, these assumptions are largely driven from a single centre cohort study and as such need clarification before they could be used for the purposes of powering a study. Based on the historical cohort studies and wide consultation within the British Society of Gastroenterology research committee and consultation with experts in the field, it is estimated that 200 patients would be reasonable for recruitment to enable the reproducibility and generalisability of this data to be established. The purpose of this study is not to produce statistically significant data in itself but to establish likely event rates and effect size to inform the power calculation for the definitive study.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Aug 2024 — Sep 2024 [monthly]
Completed NA
Status: Unknown → Completed
-
Jul 2024 — Aug 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brighton and Sussex University Hospitals NHS Trust
- Gloucestershire Hospitals NHS Foundation Trust
- Portsmouth Hospitals NHS Trust
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
- University Hospitals, Leicester
- University of Portsmouth
- Western Sussex Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .